164 filings
Page 2 of 9
6-K
wbexg
27 Nov 23
Immunoprecise Antibodies LTD. 6-K
8:31am
6-K
qycb7xi0x6d8abh7sfha
16 Nov 23
Report of Voting Results
5:13pm
6-K
mwwimko5n
13 Nov 23
Immunoprecise Antibodies LTD. 6-K
8:50am
6-K
9anxu ro8p6fp
25 Oct 23
BioStrand Unveils Groundbreaking Retrieval Augmented Generation (RAG)-Based LLM Platform Integrated with Patented HYFT Technology
8:01am
6-K
sjlu443u9s 5gnz2
23 Oct 23
Immunoprecise Antibodies LTD. 6-K
8:01am
6-K
0sw0g74 skv
20 Oct 23
Current report (foreign)
2:56pm
6-K
dj1rqo14l0
26 Sep 23
Material Change Report
11:56am
6-K
ek3hpxtwc5n
25 Sep 23
Current report (foreign)
4:46pm
6-K
8cj ogjqels7b854
19 Sep 23
Immunoprecise Antibodies LTD. 6-K
8:02am
6-K
15u8 1wxskp
18 Sep 23
Statement of Executive Compensation
2:47pm
6-K
vlj26n
14 Sep 23
Current report (foreign)
8:02am
6-K
jfw4w lqpeu1m
14 Sep 23
Immunoprecise Antibodies LTD. 6-K
8:01am
6-K
3h85f
12 Sep 23
Material Change Report
6:20pm
6-K
5dy86e dz4f0z
8 Sep 23
The Company to host an earnings conference call via webcast
8:30am
6-K
pwcvktgkj7p8nftpf
5 Sep 23
IPA appoints Barry A. Springer, Dirk Witters and Chris Buyse to the Board of Directors
8:14am
6-K
cwq0r0
15 Aug 23
Current report (foreign)
5:50pm
424B5
gnaw8z6xvr5nk
15 Aug 23
Prospectus supplement for primary offering
5:47pm
6-K/A
hqbse
14 Aug 23
Current report (foreign) (amended)
4:38pm
6-K/A
k62yf0 umkjmjlpm5h8
14 Aug 23
Current report (foreign) (amended)
4:29pm
6-K
41p nfnys1eyadnlej
9 Aug 23
Immunoprecise Antibodies LTD. 6-K
9:15am